首页> 外文期刊>Anesthesiology clinics >Dexmedetomidine: clinical application as an adjunct for intravenous regional anesthesia.
【24h】

Dexmedetomidine: clinical application as an adjunct for intravenous regional anesthesia.

机译:右美托咪定:临床应用作为静脉区域麻醉的辅助手段。

获取原文
获取原文并翻译 | 示例
           

摘要

The selective alpha-2 adrenoceptor agonist, dexmedetomidine, has been shown to be a useful, safe adjunct in perioperative medicine. Intravenous regional anesthesia is one of the simplest forms of regional anesthesia and has a high degree of success. However, intravenous regional anesthesia is limited by the development of tourniquet pain and its inability to provide postoperative analgesia. To improve block quality, prolong postdeflation analgesia, and decrease tourniquet pain, various chemical additives have been combined with local anesthetics, although with limited success. The antinociceptive effects of alpha-2 adrenoceptor agonists have been shown in animals and in humans. However, less is known about the clinical effects of dexmedetomidine when coadministered with local anesthetics in patients undergoing intravenous regional anesthesia. This review examines what is currently known to improve our understanding of the properties and application of dexmedetomidine when used as an adjunct in intravenous regional anesthesia.
机译:选择性α2肾上腺素受体激动剂右美托咪定已被证明是围手术期药物的有用,安全的辅助剂。静脉区域麻醉是区域麻醉的最简单形式之一,并具有很高的成功率。然而,静脉局部麻醉受止血带疼痛的发展及其不能提供术后镇痛的限制。为了提高阻滞质量,延长放气后镇痛和减轻止血带疼痛,尽管取得了有限的成功,但各种化学添加剂已与局麻药结合使用。已经在动物和人类中显示了α-2肾上腺素受体激动剂的抗伤害感受作用。然而,对于在静脉内区域麻醉的患者中与局部麻醉药并用时右美托咪定的临床效果知之甚少。这篇综述探讨了当用于静脉区域麻醉的辅助药物时,目前已知的哪些药物可以改善我们对右美托咪定的性质和应用的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号